Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.

Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.

Item
http://www.wikidata.org/entity/Q40025452
BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like sitePhosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging.Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior.A potential estrogen mimetic effect of a bis(ethyl)polyamine analogue on estrogen receptor positive MCF-7 breast cancer cells.Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.Combinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
P2860

Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.

Item
http://www.wikidata.org/entity/Q40025452
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Difference between genomic act ...... man ovarian cancer cell lines.
@en
type
label
Difference between genomic act ...... man ovarian cancer cell lines.
@en
prefLabel
Difference between genomic act ...... man ovarian cancer cell lines.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Difference between genomic act ...... man ovarian cancer cell lines.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921